Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,020 | 32,525 | 40,797 | 56,902 | 169,402 |
| Marketable Securities | 173,023 | 191,553 | 211,572 | 217,324 | 133,581 |
| Receivables | 427 | 2,905 | 525 | 305 | 489 |
| TOTAL | $204,985 | $229,825 | $255,597 | $276,819 | $305,189 |
| Non-Current Assets | |||||
| PPE Net | 10,535 | 10,716 | 10,601 | 10,216 | 9,973 |
| Intangibles | 30,772 | 31,025 | 31,278 | 31,532 | 31,785 |
| Other Non-Current Assets | 1,722 | 99 | 116 | 132 | 148 |
| TOTAL | $43,029 | $41,840 | $41,995 | $41,880 | $41,906 |
| Total Assets | $248,014 | $271,665 | $297,592 | $318,699 | $347,095 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,191 | 2,118 | 1,127 | N/A |
| Accounts payable and accrued liabilities | 2,603 | 1,720 | 1,187 | 3,414 | 2,243 |
| Accrued Expenses | 19,296 | 17,703 | 17,897 | 14,966 | 17,179 |
| Other current liabilities | 2,592 | N/A | N/A | N/A | 928 |
| TOTAL | $24,491 | $21,614 | $21,202 | $19,507 | $20,350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,863 | 10,679 | 11,075 | 7,346 | 6,950 |
| TOTAL | $11,863 | $10,679 | $11,075 | $7,346 | $6,950 |
| Total Liabilities | $36,354 | $32,293 | $32,277 | $26,853 | $27,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,977 | 5,976 | 5,963 | 5,960 | 5,953 |
| Common Shares | 90 | 89 | 89 | 89 | 89 |
| Retained earnings | -463,759 | -431,937 | -403,856 | -375,582 | -345,679 |
| Other shareholders' equity | 2,590 | 2,624 | 2,748 | 2,670 | 2,668 |
| TOTAL | $211,660 | $239,372 | $265,315 | $291,846 | $319,795 |
| Total Liabilities And Equity | $248,014 | $271,665 | $297,592 | $318,699 | $347,095 |